Quantitative Assessment of Tumor Responses after Radiation Therapy in a DLD-1 Colon Cancer Mouse Model Using Serial Dynamic Contrast-Enhanced Magnetic Resonance Imaging

被引:6
|
作者
Ahn, Sung Jun [1 ,2 ]
Koom, Woong Sub [3 ]
An, Chan Sik [1 ,2 ]
Lim, Joon Seok [1 ,2 ]
Lee, Seung-Koo [1 ,2 ]
Suh, Jin-Suck [1 ,2 ]
Song, Ho-Taek [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Radiol, Seoul 120752, South Korea
[2] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Seoul 120752, South Korea
[3] Yonsei Univ, Coll Med, Dept Radiat Oncol, Seoul 120752, South Korea
关键词
Colorectal cancer; radiation therapy; magnetic resonance imaging; permeability; angiogenesis; ADVANCED BREAST-CANCER; RECTAL-CANCER; NEOADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; MRI; PARAMETERS; CARCINOMA; ANGIOGENESIS; RADIOTHERAPY; MICROCIRCULATION;
D O I
10.3349/ymj.2012.53.6.1147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The purpose of this study was to investigate the predictability of pretreatment values including Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) derived parameters (K-trans, K-ep and V-e), early changes in parameters (K-trans, tumor volume), and heterogeneity (standard deviation of K-trans) for radiation therapy responses via a human colorectal cancer xenograft model. Materials and Methods: A human colorectal cancer xenograft model with DLD-1 cancer cells was produced in the right hind limbs of five mice. Tumors were irradiated with 3 fractions of 3 Gy each for 3 weeks. Baseline and follow up DCE-MRI were performed. Quantitative parameters (K-trans, K-ep and V-e) were calculated based on the Tofts model. Early changes in K-trans, standard deviation (SD) of K-trans, and tumor volume were also calculated. Tumor responses were evaluated based on histology. With a cut-off value of 0.4 for necrotic factor, a comparison between good and poor responses was conducted. Results: The good response group (mice #1 and 2) exhibited higher pretreatment K-trans than the poor response group (mice #3, 4, and 5). The good response group tended to show lower pretreatment K-ep, higher pretreatment V-e, and larger baseline tumor volume than the poor response group. All the mice in the good response group demonstrated marked reductions in K-trans and SD value after the first radiation. All tumors showed increased volume after the first radiation therapy. Conclusion: The good response after radiation therapy group in the DLD-1 colon cancer xenograft nude mouse model exhibited a higher pretreatment K-trans and showed an early reduction in K-trans, demonstrating a more homogenous distribution.
引用
收藏
页码:1147 / 1153
页数:7
相关论文
共 50 条
  • [41] Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer using diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging
    Xu, H. D.
    Zhang, Y. Q.
    NEOPLASMA, 2017, 64 (03) : 430 - 436
  • [42] Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    Nguyen, Huyen T.
    Pohar, Kamal S.
    Jia, Guang
    Shah, Zarine K.
    Mortazavi, Amir
    Zynger, Debra L.
    Wei, Lai
    Clark, Daniel
    Yang, Xiangyu
    Knopp, Michael V.
    INVESTIGATIVE RADIOLOGY, 2014, 49 (06) : 390 - 395
  • [43] Feasibility of 3T Dynamic Contrast-Enhanced Magnetic Resonance-Guided Biopsy in Localizing Local Recurrence of Prostate Cancer After External Beam Radiation Therapy
    Yakar, Derya
    Hambrock, Thomas
    Huisman, Henkjan
    Hulsbergen-van de Kaa, Christina A.
    van Lin, Emile
    Vergunst, Henk
    Hoeks, Caroline M. A.
    van Oort, Inge M.
    Witjes, J. Alfred
    Barentsz, Jelle O.
    Futterer, Jurgen J.
    INVESTIGATIVE RADIOLOGY, 2010, 45 (03) : 121 - 125
  • [44] Value of dynamic contrast-enhanced magnetic resonance imaging quantitative parameters in evaluating the efficacy of neoadjuvant chemoradiotherapy for cervical cancer
    Yi, M.
    Hong, R.
    Zhang, Zh.
    Xiong, Z.
    Ran, J.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2024, 22 (04): : 1067 - 1074
  • [45] Dynamic contrast-enhanced magnetic resonance imaging parameter changes as an early biomarker of tumor responses following radiation therapy in patients with spinal metastases: a systematic review
    Mulyadi, Rahmad
    Putri, Pungky Permata
    Handoko
    Zairinal, Ramdinal Aviesena
    Prihartono, Joedo
    RADIATION ONCOLOGY JOURNAL, 2023, 41 (04): : 225 - 236
  • [46] Assessment of uterine enhancement rate after abdominal radical trachelectomy using dynamic contrast-enhanced magnetic resonance imaging
    Hiroshi Makino
    Hiroki Kato
    Tatsuro Furui
    Yoh Hayasaki
    Ken-ichirou Morishige
    Masayuki Kanematsu
    Archives of Gynecology and Obstetrics, 2016, 293 : 625 - 632
  • [47] NONINVASIVE ASSESSMENT OF TUMOR MICROENVIRONMENT USING DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING AND 18F-FLUOROMISONIDAZOLE POSITRON EMISSION TOMOGRAPHY IMAGING IN NECK NODAL METASTASES
    Jansen, Jacobus F. A.
    Schoeder, Heiko
    Lee, Nancy Y.
    Wang, Ya
    Pfister, David. G.
    Fury, Matthew G.
    Stambuk, Hilda E.
    Humm, John L.
    Koutcher, Jason A.
    Shukla-Dave, Amita
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (05): : 1403 - 1410
  • [48] Axillary nodal prognostic impact of two-dimensional tumor heterogeneity flux in breast cancer: evaluation via dynamic contrast-enhanced magnetic resonance imaging
    Obeid, Jean-Pierre
    Stoyanova, Radka
    Zeidan, Youssef H.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (01) : 177 - 187
  • [49] Differentiation between ductal carcinoma in situ and mastopathy using dynamic contrast-enhanced magnetic resonance imaging and a model of contrast enhancement
    Nishiura, Motoko
    Tamaki, Yasuhiro
    Murase, Kenya
    EUROPEAN JOURNAL OF RADIOLOGY, 2011, 80 (03) : 740 - 743
  • [50] Radiation Injury of the Parotid Glands During Treatment for Head and Neck Cancer: Assessment Using Dynamic Contrast-Enhanced MR Imaging
    Lee, Francis Kar-ho
    King, Ann Dorothy
    Kam, Michael Koon-ming
    Ma, Brigette Buig-yue
    Yeung, David Ka-wai
    RADIATION RESEARCH, 2011, 175 (03) : 291 - 296